sellModerate
Slate Path Capital LP sold $555k of KRSA
owner at Cyclerion Therapeutics, Inc.. 357,880 shares at an average of $1.55, traded Nov 21, 2024, filed Nov 25, 2024.
Warning score
51Value
$555k
357,880 shares
Holdings after
0
-100% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
- +12Role10% owner
- +19Trade size$555k at market
- +20Share of holdings soldSold 100% of holdings
- 0ClusterNo other insider selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0000902664-24-006775, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Nov 21, 2024 | SOpen-market sale Common Stock, no par valueindirect: See footnote | -357,880 | $1.55 | $555k | 0 | Nov 25, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.